These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38629266)

  • 1. Aggregates in apheresis-derived platelet concentrates: A 5-year single-centre experience.
    Vinković M; Hećimović A; Jukić I; Vuk T
    Vox Sang; 2024 Jul; 119(7):686-692. PubMed ID: 38629266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent aggregates in apheresis platelet concentrates are commonly collected from donors with a history of aggregate donation.
    Feys HB; Pottel H; Coene J; Vandewalle G; Vandekerckhove P; Compernolle V
    Vox Sang; 2016 Nov; 111(4):431-433. PubMed ID: 27509321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-yield thrombocytapheresis on the quality of platelet products.
    Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent aggregates in apheresis platelet concentrates.
    Feys HB; Coene J; Devloo R; Van Aelst B; Pottel H; Vandekerckhove P; Compernolle V
    Vox Sang; 2015 May; 108(4):368-77. PubMed ID: 25754290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentrates.
    Feys HB; Van Aelst B; Devloo R; Vandekerckhove P; Compernolle V
    Vox Sang; 2016 May; 110(4):344-51. PubMed ID: 26646710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and quality evaluation of apheresis vs random-donor platelet concentrates stored for 7 days.
    Hussein E
    Transfus Med; 2015 Feb; 25(1):20-6. PubMed ID: 25808050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators.
    Keklik M; Eser B; Kaynar L; Sivgin S; Keklik E; Solmaz M; Ozturk A; Buyukoglan R; Yay M; Cetin M; Unal A
    J Clin Apher; 2015 Jun; 30(3):171-5. PubMed ID: 25230340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to vWF-coated beads and soluble p-selectin to characterize apheresis platelets: a comparison of three cell separators.
    Stiegler G; Eichelberger B; Leitner G; Jilma B; Hoecker P; Panzer S
    Transfusion; 2002 Mar; 42(3):375-9. PubMed ID: 11961245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freezing of Apheresis Platelet Concentrates in 6% Dimethyl Sulfoxide: The First Preliminary Study in Turkey.
    Yılmaz S; Çetinkaya RA; Eker İ; Ünlü A; Uyanık M; Tapan S; Pekoğlu A; Pekel A; Erkmen B; Muşabak U; Yılmaz S; Avcı İY; Avcu F; Kürekçi E; Eyigün CP
    Turk J Haematol; 2016 Mar; 33(1):28-33. PubMed ID: 25912150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of platelet yield, donor's characteristic and apheresis instruments in China.
    Yin G; Xu J; Shen Z; Wang Y; Zhu F; Lv H
    Transfus Apher Sci; 2013 Dec; 49(3):608-12. PubMed ID: 23978555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended storage of single-donor apheresis platelets in CLX blood bags: effect of storage on platelet morphology, viability and in vitro function.
    Kenney DM; Peterson JJ; Smith JW
    Vox Sang; 1988; 54(1):24-33. PubMed ID: 3348019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet concentrates, from whole blood or collected by apheresis?
    van der Meer PF
    Transfus Apher Sci; 2013 Apr; 48(2):129-31. PubMed ID: 23535511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Yield and Some Donor-Related Predictors in a Single Donor Apheresis: Report from a Nigerian Tertiary Hospital.
    Ugwu GC; Okoye HC; Nnachi OC; Nwani E; Nnachi OA; Ezenwenyi IP; Ugwu NI; Okoye AE
    West Afr J Med; 2022 Dec; 39(12):1280-1284. PubMed ID: 36583368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet concentrates derived from buffy coat and apheresis: biochemical and functional differences.
    Böck M; Rahrig S; Kunz D; Lutze G; Heim MU
    Transfus Med; 2002 Oct; 12(5):317-24. PubMed ID: 12383338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
    Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
    Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality validation of platelets obtained from the Haemonetics and Trima Accel automated blood-collection systems.
    Wang HH; Liao LN; Lin CL; Yen LL; Hsiao YM; Ko JL
    Transfus Clin Biol; 2021 Feb; 28(1):44-50. PubMed ID: 33227455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.